Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine for improvement of liver enzymes in patients treated with methotrexate and 6-mercaptopurine
IRCT201604297677N5Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levocarnitine in acute lymphoblastic leukemia (ALL), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Change in liver enzymes. Started May 2016; status: completed.
02
Drugs
levocarnitine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT201604297677N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201604297677N5.